慢性压力过载模型中的心脏淋巴功能障碍的分子决定因素
Coraline Heron1, Theo Lemarcis1, Océane Laguerre1
1UnivRouen Normandy, INSERM UMR1096 (EnVI Laboratory), Rouen, F-76000, France.
EMBO molecular medicine
|December 11, 2025
概括
心脏淋巴损失和屏障功能障碍有助于心力衰竭 (HF) 的并发症. 这项研究揭示了改善淋巴排水和心血管疾病 (CVD) 结果的分子标.
科学领域:
- 心血管生物学 心血管生物学
- 淋巴研究 淋巴研究
- 分子医学是分子医学.
背景情况:
- 心血管疾病 (CVD) 与心脏淋巴功能障碍和淋巴排水障碍有关.
- 了解淋巴功能障碍的分子机制对于开发有效治疗方法至关重要.
研究的目的:
- 为了研究心脏淋巴功能障碍的机制,在压力过载引起的心力衰竭 (HF) 的小鼠模型中.
- 确定用于恢复心血管疾病中淋巴健康的分子标.
主要方法:
- 单细胞RNA测序 (scRNAseq) 心脏淋巴内皮细胞 (LEC) 和血液血管内皮细胞 (BEC) 在小鼠HF模型中.
- 在小鼠中诱导压力超负荷的横静脉收缩 (TAC).
- 使用免疫组织化学和人类LEC培养物的验证.
主要成果:
- 在BALB/c小鼠中,压力过载诱导了淋巴毛细血管扩张和门损失,但不是C57BL/6J小鼠.
- 差异基因表达分析显示,TAC后BALB/c小鼠的淋巴结部件减少.
- 在TAC后的心脏LEC中显著一部分差异表达的基因在IL-1β刺激的人类LEC中也发生了变化.
结论:
- 淋巴的损失和淋巴屏障的失调会导致压力过载引起的HF的排水受损.
- 尽管淋巴血管生成和免疫细胞吸引力得到保护,淋巴功能障碍仍然存在.
- 已识别的分子点为治疗心血管疾病提供了治疗干预的潜力.
相关概念视频
Heart Failure II: Pathophysiology
668
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
668
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Cardiomyopathy IV: Restrictive Cardiomyopathy
426
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
426


